Metabolic and transcriptional activities of Staphylococcus aureus challenged with high-doses of daptomycin

International Journal of Medical Microbiology

Volumn 304, Issue 8, 2014, Pages 931-940

  Lechner, Sabrina ^a   Prax, Marcel ^a   Lange, Birgit ^b   Huber, Claudia ^b   Eisenreich, Wolfgang ^b   Herbig, Alexander ^a   Nieselt, Kay ^a   Bertram, Ralph ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Daptomycin; Drug tolerance; Persisters; Staphylococcus aureus

Indexed keywords

CARBON 13; DAPTOMYCIN; ANTIINFECTIVE AGENT; GLUCOSE;

ARTICLE; BACTERIAL CELL; CITRIC ACID CYCLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RESPONSE; GENE EXPRESSION; GLUCOSE METABOLISM; GROWTH CURVE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OBSERVATIONAL STUDY; STAPHYLOCOCCUS AUREUS; DRUG EFFECTS; DRUG TOLERANCE; GENE EXPRESSION PROFILING; GENETICS; ISOTOPE LABELING; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGICAL STRESS; PROTEIN SYNTHESIS;

ANTI-BACTERIAL AGENTS; CITRIC ACID CYCLE; DAPTOMYCIN; DRUG TOLERANCE; GENE EXPRESSION PROFILING; GLUCOSE; ISOTOPE LABELING; MICROARRAY ANALYSIS; PROTEIN BIOSYNTHESIS; STAPHYLOCOCCUS AUREUS; STRESS, PHYSIOLOGICAL;

EID: 84912010707     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2014.05.008     Document Type: Article

References (82)

1. Ackerman R.S., Cozzarelli N.R., Epstein W. Accumulation of toxic concentrations of methylglyoxal by wild-type Escherichia coli K-12. J. Bacteriol. 1974, 119:357-362.
2. Alborn W.E., Allen N.E., Preston D.A. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother. 1991, 35:2282-2287.
3. Allen N.E., Alborn W.E., Hobbs J.N. Inhibition of membrane potential-dependent amino acid transport by daptomycin. Antimicrob. Agents Chemother. 1991, 35:2639-2642.
4. Allison K.R., Brynildsen M.P., Collins J.J. Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr. Opin. Microbiol. 2011, 14:593-598.
5. Allison K.R., Brynildsen M.P., Collins J.J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 2011, 473:216-220.
6. Amato S.M., Orman M.A., Brynildsen M.P. Metabolic control of persister formation in Escherichia coli. Mol. Cell 2013, 50:475-487.
7. Balaban N.Q., Gerdes K., Lewis K., McKinney J.D. A problem of persistence: still more questions than answers?. Nat. Rev. Microbiol. 2013, 11:587-591.
8. Battke F., Nieselt K. Mayday SeaSight: combined analysis of deep sequencing and microarray data. PLoS One 2011, 6:e16345.
9. Battke F., Symons S., Nieselt K. Mayday-integrative analytics for expression data. BMC Bioinformatics 2010, 11:121.
10. Bayer A.S., Schneider T., Sahl H.G. Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann. N. Y. Acad. Sci. 2013, 1277:139-158.
11. Benson C.A., Beaudette F., Trenholm G. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms. J. Antimicrob. Chemother. 1987, 20:191-196.
12. Bigger J. Treatment of staphylococcal infections with penicillin. Lancet 1944, 244:497-500.
13. Bokinsky G., Baidoo E.E., Akella S., Burd H., Weaver D., Alonso-Gutierrez J., Garcia-Martin H., Lee T.S., Keasling J.D. HipA-triggered growth arrest and beta-lactam tolerance in Escherichia coli are mediated by RelA-dependent ppGpp synthesis. J. Bacteriol. 2013, 195:3173-3182.
14. Casadesús J., Low D.A. Programmed heterogeneity: epigenetic mechanisms in bacteria. J. Biol. Chem. 2013, 288:13929-13935.
15. Cirz R.T., Jones M.B., Gingles N.A., Minogue T.D., Jarrahi B., Peterson S.N., Romesberg F.E. Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin. J. Bacteriol. 2007, 189:531-539.
16. Cohen N.R., Lobritz M.A., Collins J.J. Microbial persistence and the road to drug resistance. Cell Host Microbe 2013, 13:632-642.
17. Conlon B.P., Nakayasu E.S., Fleck L.E., LaFleur M.D., Isabella V.M., Coleman K., Leonard S.N., Smith R.D., Adkins J.N., Lewis K. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 2013, 503:365-370.
18. De Groote V.N., Verstraeten N., Fauvart M., Kint C.I., Verbeeck A.M., Beullens S., Cornelis P., Michiels J. Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol. Lett. 2009, 297:73-79.
19. DeLeo F.R., Otto M., Kreiswirth B.N., Chambers H.F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010, 375:1557-1568.
20. Dhar N., McKinney J.D. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 2007, 10:30-38.
21. Dunman P.M., Mounts W., McAleese F., Immermann F., Macapagal D., Marsilio E., McDougal L., Tenover F.C., Bradford P.A., Petersen P.J., Projan S.J., Murphy E. Uses of Staphylococcus aureus GeneChips in genotyping and genetic composition analysis. J. Clin. Microbiol. 2004, 42:4275-4283.
22. Eisenreich W., Dandekar T., Heesemann J., Goebel W. Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nature reviews. Microbiology 2010, 8:401-412.
23. 13C isotopologue perturbation studies of Listeria monocytogenes carbon metabolism and its modulation by the virulence regulator PrfA. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2040-2045.
24. Emmett M., Kloos W.E. Amino acid requirements of staphylococci isolated from human skin. Can. J. Microbiol. 1975, 21:729-733.
25. Fauvart M., De Groote V.N., Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 2011, 60:699-709.
26. Sa, an endoribonuclease from Staphylococcus aureus. J. Bacteriol. 2007, 189:8871-8879.
27. Fuchs P.C., Barry A.L., Brown S.D. In vitro bactericidal activity of daptomycin against staphylococci. J. Antimicrob. Chemother. 2002, 49:467-470.
28. Fung D.K., Chan E.W., Chin M.L., Chan R.C. Delineation of a bacterial starvation stress response network which can mediate antibiotic tolerance development. Antimicrob. Agents Chemother. 2010, 54:1082-1093.
29. Gilbert P., Collier P.J., Brown M.R. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob. Agents Chemother. 1990, 34:1865-1868.
30. Girgis H.S., Harris K., Tavazoie S. Large mutational target size for rapid emergence of bacterial persistence. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12740-12745.
31. Gladstone G.P. The nutrition of Staphylococcus aureus; nitrogen requirements. Br. J. Exp. Pathol. 1937, 18:322-333.
32. Götz F. Staphylococcus and biofilms. Mol. Microbiol. 2002, 43:1367-1378.
33. Härtel T., Eylert E., Schulz C., Petruschka L., Gierok P., Grubmüller S., Lalk M., Eisenreich W., Hammerschmidt S. Characterization of central carbon metabolism of Streptococcus pneumoniae by isotopologue profiling. J. Biol. Chem. 2012, 287:4260-4274.
34. Helaine S., Cheverton A.M., Watson K.G., Faure L.M., Matthews S.A., Holden D.W. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 2014, 343:204-208.
35. Humphries R.M., Pollett S., Sakoulas G. A current perspective on daptomycin for the clinical microbiologist. Clin. Microbiol. Rev. 2013, 26:759-780.
36. Iordanescu S., Surdeanu M. Two restriction and modification systems in Staphylococcus aureus NCTC8325. J. Gen. Microbiol. 1976, 96:277-281.
37. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31:e15.
38. Jõers A., Kaldalu N., Tenson T. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J. Bacteriol. 2010, 192:3379-3384.
39. Johnson P.J., Levin B.R. Pharmacodynamics, Population Dynamics, and the Evolution of Persistence in Staphylococcus aureus. PLoS Genet 2013, 9:e1003123.
40. Keren I., Minami S., Rubin E., Lewis K. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio 2011, 2:e00100-e00111.
41. Keren I., Shah D., Spoering A., Kaldalu N., Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 2004, 186:8172-8180.
42. Keren I., Wu Y., Inocencio J., Mulcahy L.R., Lewis K. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 2013, 339:1213-1216.
43. Kim J.H., O'Brien K.M., Sharma R., Boshoff H.I., Rehren G., Chakraborty S., Wallach J.B., Monteleone M., Wilson D.J., Aldrich C.C., Barry C.E., Rhee K.Y., Ehrt S., Schnappinger D. A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:19095-19100.
44. Kint C.I., Verstraeten N., Fauvart M., Michiels J. New-found fundamentals of bacterial persistence. Trends Microbiol. 2012, 20:577-585.
45. Kohanski M.A., Dwyer D.J., Hayete B., Lawrence C.A., Collins J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130:797-810.
46. Kotte O., Zaugg J.B., Heinemann M. Bacterial adaptation through distributed sensing of metabolic fluxes. Mol. Syst. Biol. 2010, 6:355.
47. Lechner S., Lewis K., Bertram R. Staphylococcus aureus Persisters Tolerant to Bactericidal Antibiotics. J. Mol. Microbiol. Biotechnol. 2012, 22:235-244.
48. 13C] glucose and mass isotopomer analysis. Biochem. Med. Metab. Biol. 1991, 45:298-309.
49. Lewis K. Persister cells. Annu. Rev. Microbiol. 2010, 64:357-372.
50. Lewis K. Persister cells and the paradox of chronic infections. Microbe 2010, 5:429-437.
51. Liebeke M., Meyer H., Donat S., Ohlsen K., Lalk M. A metabolomic view of Staphylococcus aureus and its ser/thr kinase and phosphatase deletion mutants: involvement in cell wall biosynthesis. Chem. Biol. 2010, 17:820-830.
52. Liu J., Wang Q., Zou H., Liu Y., Wang J., Gan K., Xiang J. Glucose metabolic flux distribution of Lactobacillus amylophilus during lactic acid production using kitchen waste saccharified solution. Microb. Biotechnol. 2013, 6:685-693.
53. Liu Y., Imlay J.A. Cell death from antibiotics without the involvement of reactive oxygen species. Science 2013, 339:1210-1213.
54. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
55. Luidalepp H., Jõers A., Kaldalu N., Tenson T. Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J. Bacteriol. 2011, 193:3598-3605.
56. Maisonneuve E., Castro-Camargo M., Gerdes K. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 2013, 154:1140-1150.
57. Manina G., McKinney J.D. A single-cell perspective on non-growing but metabolically active (NGMA) bacteria. Curr. Top. Microbiol. Immunol. 2013, 374:135-161.
58. Marincola G., Schäfer T., Behler J., Bernhardt J., Ohlsen K., Goerke C., Wolz C. RNase Y of Staphylococcus aureus and its role in the activation of virulence genes. Mol. Microbiol. 2012, 85:817-832.
59. Mascio C.T., Alder J.D., Silverman J.A. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob. Agents Chemother. 2007, 51:4255-4260.
60. Masmoudi S., Denis M., Maalej S. Inactivation of the gene katA or sodA affects the transient entry into the viable but non-culturable response of Staphylococcus aureus in natural seawater at low temperature. Mar. Pollut. Bull. 2010, 60:2209-2214.
61. Muthaiyan A., Silverman J.A., Jayaswal R.K., Wilkinson B.J. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob. Agents Chemother. 2008, 52:980-990.
62. Nguyen D., Joshi-Datar A., Lepine F., Bauerle E., Olakanmi O., Beer K., McKay G., Siehnel R., Schafhauser J., Wang Y., Britigan B.E., Singh P.K. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011, 334:982-986.
63. Orman M.A., Brynildsen M.P. Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob. Agents Chemother. 2013, 57:3230-3239.
64. Orman M.A., Brynildsen M.P. Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob. Agents Chemother. 2013, 57:4398-4409.
65. Pasquaroli S., Zandri G., Vignaroli C., Vuotto C., Donelli G., Biavasco F. Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms. J. Antimicrob. Chemother. 2013, 68:1812-1817.
66. Pinto D., Santos M.A., Chambel L. Thirty years of viable but nonculturable state research: unsolved molecular mechanisms. Crit. Rev. Microbiol. 2013, [Epub ahead of print].
67. Resch A., Rosenstein R., Nerz C., Götz F. Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl. Environ. Microbiol. 2005, 71:2663-2676.
68. Roostalu J., Jõers A., Luidalepp H., Kaldalu N., Tenson T. Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol. 2008, 8:68.
69. Sadykov M.R., Zhang B., Halouska S., Nelson J.L., Kreimer L.W., Zhu Y., Powers R., Somerville G.A. Using NMR metabolomics to investigate tricarboxylic acid cycle-dependent signal transduction in Staphylococcus epidermidis. J. Biol. Chem. 2010, 285:36616-36624.
70. Shah D., Zhang Z., Khodursky A., Kaldalu N., Kurg K., Lewis K. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 2006, 6:53.
71. Silverman J.A., Perlmutter N.G., Shapiro H.M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 2003, 47:2538-2544.
72. Somerville G.A., Said-Salim B., Wickman J.M., Raffel S.J., Kreiswirth B.N., Musser J.M. Correlation of acetate catabolism and growth yield in Staphylococcus aureus: implications for host-pathogen interactions. Infect. Immun. 2003, 71:4724-4732.
73. Spoering A.L., Vulic M., Lewis K. GlpD and PlsB participate in persister cell formation in Escherichia coli. J. Bacteriol. 2006, 188:5136-5144.
74. Staley J.T., Konopka A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu. Rev. Microbiol. 1985, 39:321-346.
75. Steenbergen J.N., Alder J., Thorne G.M., Tally F.P. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 2005, 55:283-288.
76. Trudeau K., Vu K.D., Shareck F., Lacroix M. Capillary electrophoresis separation of protein composition of gamma-irradiated food pathogens Listeria monocytogenes and Staphylococcus aureus. PLoS ONE 2012, 7:e32488.
77. Wang X., Wood T.K. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl. Environ. Microbiol. 2011, 77:5577-5583.
78. Weiss E.C., Spencer H.J., Daily S.J., Weiss B.D., Smeltzer M.S. Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation. Antimicrob. Agents Chemother. 2009, 53:2475-2482.
79. Weiss E.C., Zielinska A., Beenken K.E., Spencer H.J., Daily S.J., Smeltzer M.S. Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo. Antimicrob. Agents Chemother. 2009, 53:4096-4102.
80. Yoshizumi S., Zhang Y., Yamaguchi Y., Chen L., Kreiswirth B.N., Inouye M. Staphylococcus aureus YoeB homologues inhibit translation initiation. J. Bacteriol. 2009, 191:5868-5872.
81. Yu W., Leibig M., Schäfer T., Bertram R., Ohlsen K., Götz F. Mevalonate auxotrophic mutant of Staphylococcus aureus can adapt to mevalonate depletion. Antimicrob. Agents Chemother. 2013, 57:5710-5713.
82. Zandri G., Pasquaroli S., Vignaroli C., Talevi S., Manso E., Donelli G., Biavasco F. Detection of viable but non-culturable staphylococci in biofilms from central venous catheters negative on standard microbiological assays. Clin. Microbiol. Infect. 2012, 18:E259-E261.